Peter Hoehn, J.d.

Biography

 Peter Hoehn, J.D. is responsible for setting overall business objectives and strategic priorities for diagnostic solutions for Neuroscience, Immunology and Cardiovascular & Metabolism, and for leading development and implementation of identified companion and complementary diagnostics opportunities that support the short- and long-term growth objectives of these three therapeutic areas. In this role, Peter also has responsibility for developing health economic, reimbursement and pricing strategies across the Janssen Diagnostics portfolio. Peter obtained a B.A. in Government and Economics from the College of William and Mary in Williamsburg, Virginia, and a J.D. from New York University in New York City. Peter started his career as a corporate lawyer and entered the pharmaceutical industry as an attorney for Bristol-Myers Squibb. He then moved in to various strategy, marketing and sales management roles, primarily in the oncology and cardiovascular areas. Peter joined Johnson & Johnson in 2003 in the Pharmaceuticals Group Strategic Marketing organization as a Global Commercial Leader, and in 2005 was promoted to Global Marketing Leader – Neurology, where he had global commercial responsibility for in-line neurology products as well as products in late-stage development. In 2008 Peter joined the Ortho Clinical Diagnostics (OCD) organization as Global Marketing Leader and was promoted to Vice President for Worldwide Marketing and Strategic Marketing in 2010. In this role, Peter and his team set overall marketing strategies and plans for the worldwide clinical laboratory diagnostics business, defined and managed the pipeline of new products, and identified and assessed new growth opportunities. Peter was also an original team member of the Janssen Companion Diagnostics Center of Excellence while at OCD.

Research Interest

  Peter joined Johnson & Johnson in 2003 in the Pharmaceuticals Group Strategic Marketing organization as a Global Commercial Leader, and in 2005 was promoted to Global Marketing Leader – Neurology, where he had global commercial responsibility for in-line neurology products as well as products in late-stage development. In 2008 Peter joined the Ortho Clinical Diagnostics (OCD) organization as Global Marketing Leader and was promoted to Vice President for Worldwide Marketing and Strategic Marketing in 2010. In this role, Peter and his team set overall marketing strategies and plans for the worldwide clinical laboratory diagnostics business, defined and managed the pipeline of new products, and identified and assessed new growth opportunities. Peter was also an original team member of the Janssen Companion Diagnostics Center of Excellence while at OCD.